V2 Capital’s Pfizer PFE Stock Holding History

V2 Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$5.45M	Sell	165,095 -64,069	-28%	-$2.04M	2.26%	6
2014 Q4	$6.77M	Sell	229,164 -7,963	-3%	-$228K	2.8%	17
2014 Q3	$6.65M	Buy	237,127 +16,829	+8%	+$472K	2.74%	27
2014 Q2	$6.2M	Buy	220,298 +151	+0.1%	+$4.3K	2.47%	36
2014 Q1	$6.71M	Buy	220,147 +2,981	+1%	+$88.9K	2.78%	13
2013 Q4	$6.31M	Buy	+217,166	New	+$6.32M	2.63%	34

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

V2 Capital's PFE Position: Q1 2015 in Review

V2 Capital reduced its Pfizer (PFE) stake by 28% in Q1 2015, selling an estimated $2.04M and leaving 165,095 shares worth $5.45M. The position accounts for 2.26% of the portfolio, ranked #6.

V2 Capital first reported a position in PFE in Q4 2013 and has held it in 6 quarters since. The position peaked at $6.77M in Q4 2014. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

V2 Capital held 165,095 shares of Pfizer worth $5.45M as of Q1 2015.
V2 Capital sold 64,069 Pfizer shares in Q1 2015, an estimated $2.04M.
Pfizer made up 2.26% of V2 Capital's portfolio in Q1 2015, its #6 holding.
V2 Capital first reported a position in Pfizer in Q4 2013 and has held it in 6 quarters since.
V2 Capital's Pfizer position peaked at $6.77M in Q4 2014.
1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on V2 Capital's 13F filing for Q1 2015, filed 5 May 2015.